anti-MUC1-Ab (Protheragen)

N/A

Report date: 2025/03/18 18:06:16

Base Information

Drug Nameanti-MUC1-Ab (Protheragen)
Drug Alias Nameanti-MUC1-antibody (Protheragen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMucin-1 inhibitors
TargetsMucin-1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtheragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtheragen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A